Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DFTX Definium Therapeutics

Market Closed 04-17 16:00:00 EDT

22.68

+0.22

+0.98%

盘后23.00

+0.32+1.41%

19:48 EDT

High23.00	Low22.01	Vol2.12M
Open22.86	D1 Closing22.46	Amplitude4.41%
Mkt Cap2.26B	Tradable Cap2.13B	Total Shares99.70M
T/O47.74M	T/O Rate2.26%	Tradable Shares93.74M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":22.68,"timestamp":1776456000000,"preClose":22.46,"halted":0,"volume":2122197,"hourTrading":{"tag":"盘后","latestPrice":23,"preClose":22.68,"latestTime":"19:48 EDT","volume":29672,"amount":673377.8367,"timestamp":1776469736107,"change":0.32,"changeRate":0.014109,"amplitude":0.029541},"delay":0,"changeRate":0.009795191451469228,"floatShares":93736700,"shares":99698129,"eps":-2.059999,"marketStatus":"Market Closed","change":0.22,"latestTime":"04-17 16:00:00 EDT","open":22.86,"high":23,"low":22.01,"amount":47744610.868416,"amplitude":0.044078,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.059999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776672000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":22.46,"preHourTrading":{"tag":"盘前","latestPrice":22.86,"preClose":22.46,"latestTime":"09:29 EDT","volume":12386,"amount":284117.62346000003,"timestamp":1776432599999,"change":0.4,"changeRate":0.017809,"amplitude":0.022796},"postHourTrading":{"tag":"盘后","latestPrice":23,"preClose":22.68,"latestTime":"19:48 EDT","volume":29672,"amount":673377.8367,"timestamp":1776469736107,"change":0.32,"changeRate":0.014109,"amplitude":0.029541},"volumeRatio":1.173252746083937,"impliedVol":0.737,"impliedVolPercentile":0.1587},"requestUrl":"/m/hq/s/DFTX","defaultTab":"news","newsList":[{"id":"2628752745","title":"Definium Therapeutics Inc - Supports White House Executive Order on Mental Health Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2628752745","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628752745?lang=en_us&edition=fundamental","pubTime":"2026-04-19 07:38","pubTimestamp":1776555532,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260418:nFWN41102Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628752069","title":"Definium Therapeutics Inc- Developing DT120 Odt for Generalized Anxiety Disorder, Major Depressive Disorder, and Other Serious Brain Health Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2628752069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628752069?lang=en_us&edition=fundamental","pubTime":"2026-04-19 07:38","pubTimestamp":1776555532,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260418:nFWN41102Y:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628752746","title":"Definium Therapeutics backs White House order to accelerate psychedelic mental health treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2628752746","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628752746?lang=en_us&edition=fundamental","pubTime":"2026-04-19 07:38","pubTimestamp":1776555499,"startTime":"0","endTime":"0","summary":"Definium Therapeutics backed a newly signed White House executive order aimed at accelerating research, development, and responsible access to treatments for serious mental illness, including psychedelic medicines.CEO Rob Barrow said psychedelic medicines could become meaningful new options for patients.Definium highlighted its late-stage clinical program for DT120  in generalized anxiety disorder, major depressive disorder.Company said streamlined regulatory pathways, cross-agency coordination could speed translation of innovation into care.Definium emphasized FDA evidence-based review as key route to delivering psychedelic therapies safely to patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. publishe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260418:nNDL2QG6xg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628869017","title":"Definium Therapeutics Anxiety Drug A Multi-Billion Opportunity: Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2628869017","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628869017?lang=en_us&edition=fundamental","pubTime":"2026-04-18 02:06","pubTimestamp":1776449160,"startTime":"0","endTime":"0","summary":"Stifel starts Definium coverage, citing strong DT120 potential in anxiety and key 2026 trial catalysts shaping outlook.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/17/Mental-Health-Care-Therapy-Concept--Psyc.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/17/Mental-Health-Care-Therapy-Concept--Psyc.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/analyst-stock-ratings/initiation/26/04/51894510/definium-therapeutics-anxiety-drug-a-multi-billion-opportunity-analyst","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/initiation/26/04/51894510/definium-therapeutics-anxiety-drug-a-multi-billion-opportunity-analyst","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628036352","title":"Stifel Initiates Definium Therapeutics at Buy With $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2628036352","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628036352?lang=en_us&edition=fundamental","pubTime":"2026-04-17 19:28","pubTimestamp":1776425296,"startTime":"0","endTime":"0","summary":"Definium Therapeutics, Inc. (DFTX) has an average rating of buy and mean price target of $36.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DFTX","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628270715","title":"Definium Therapeutics Inc : Stifel Initiates Coverage With Buy Rating; Price Target $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2628270715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628270715?lang=en_us&edition=fundamental","pubTime":"2026-04-17 18:47","pubTimestamp":1776422838,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nFWN410022:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628517272","title":"Definium Therapeutics (DFTX): Reinforced Buy on Upcoming DT120 Data Catalysts and Commercialization Roadmap","url":"https://stock-news.laohu8.com/highlight/detail?id=2628517272","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628517272?lang=en_us&edition=fundamental","pubTime":"2026-04-17 17:25","pubTimestamp":1776417922,"startTime":"0","endTime":"0","summary":"Needham analyst Ami Fadia has maintained their bullish stance on DFTX stock, giving a Buy rating yesterday. Ami Fadia has given his Buy rating due ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/definium-therapeutics-dftx-reinforced-buy-on-upcoming-dt120-data-catalysts-and-commercialization-roadmap-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/definium-therapeutics-dftx-reinforced-buy-on-upcoming-dt120-data-catalysts-and-commercialization-roadmap-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628275601","title":"U.S. RESEARCH ROUNDUP-Adobe, Chevron, Exxon Mobil","url":"https://stock-news.laohu8.com/highlight/detail?id=2628275601","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628275601?lang=en_us&edition=fundamental","pubTime":"2026-04-17 15:36","pubTimestamp":1776411406,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Adobe, Chevron, Exxon MobilApril 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adobe, Chevron","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nL8N4100D8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AR","AXGN","BILL","CMGG","FICO","ABT","AB","AMRX","CF","COTG","CFG","ENOV","FAST","AZYY","ADBG","CGON","COST","CSX","DOMO","ADC","EXC","LNT","ACHC","AMZZ","BX","FANG","BK","AMZN","CCI","SCHW","ADBE","ESE","XOMO","APA","AA","CACC","BDX","CTBI","COSW","AMZD","BAND","WMS","CHRD","CVX","EFX","XOMZ","XOM","DFTX","XOMX","CMG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628241827","title":"Definium Therapeutics initiated with a Buy at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2628241827","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628241827?lang=en_us&edition=fundamental","pubTime":"2026-04-17 04:25","pubTimestamp":1776371125,"startTime":"0","endTime":"0","summary":"Stifel analyst Paul Matteis initiated coverage of Definium Therapeutics (DFTX) with a Buy rating and $30 price target The firm is citing its view f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-initiated-with-a-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-initiated-with-a-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","SF","BK4127","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627121292","title":"Definium Therapeutics Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2627121292","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627121292?lang=en_us&edition=fundamental","pubTime":"2026-04-16 23:46","pubTimestamp":1776354360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 16, 2026 11:46 ET (15:46 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627301291","title":"Definium Therapeutics price target raised to $38 from $25 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2627301291","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627301291?lang=en_us&edition=fundamental","pubTime":"2026-04-16 18:20","pubTimestamp":1776334822,"startTime":"0","endTime":"0","summary":"Canaccord analyst Sumant Kulkarni raised the firm’s price target on Definium Therapeutics (DFTX) to $38 from $25 and keeps a Buy rating on the shar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-38-from-25-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-38-from-25-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626190761","title":"Definium Therapeutics Initiated at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2626190761","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626190761?lang=en_us&edition=fundamental","pubTime":"2026-04-10 20:48","pubTimestamp":1775825280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 10, 2026 08:48 ET (12:48 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626942381","title":"Piper Sandler Initiates Definium Therapeutics at Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2626942381","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626942381?lang=en_us&edition=fundamental","pubTime":"2026-04-10 19:21","pubTimestamp":1775820072,"startTime":"0","endTime":"0","summary":"Definium Therapeutics, Inc. (DFTX) has an average rating of buy and mean price target of $36.21, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626678961","title":"U.S. RESEARCH ROUNDUP-Chevron, Littelfuse, Parker-Hannifin","url":"https://stock-news.laohu8.com/highlight/detail?id=2626678961","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626678961?lang=en_us&edition=fundamental","pubTime":"2026-04-10 15:38","pubTimestamp":1775806689,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Chevron, Littelfuse, Parker-HannifinApril 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies on Friday, inclu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nL4N40T0L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTC","ABBV","IE00BGHQF748.EUR","CLF","COHX","IE00B2B36J28.USD","INTW","NAKA","BRBR","COHR","LINT","CC","FRPT","BK4592","CAI","ALAB","CVX","LITX","AIM","ADBG","INFQ","DOCU","LU2211815571.USD","ADSK","ASRT","ADBE","DAR","CCC","HRI","DE","ELVN","LABX","CBZ","AMPL","ITW","LSCC","ESAB","CL","AMP","GWRE","HUBS","FNF","LU2125154778.USD","STZ","DOW","LFUS","GRAL","DFTX","LITE","CE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626168420","title":"Definium Therapeutics Inc : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $49","url":"https://stock-news.laohu8.com/highlight/detail?id=2626168420","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626168420?lang=en_us&edition=fundamental","pubTime":"2026-04-10 11:30","pubTimestamp":1775791850,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nFWN40S15X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626186451","title":"Definium Therapeutics to present at Needham, RBC healthcare investor conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2626186451","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626186451?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:00","pubTimestamp":1775732429,"startTime":"0","endTime":"0","summary":"Definium Therapeutics management will join Needham Virtual Healthcare Conference fireside chat on April 16, 2026 at 3:00 PM EDT.Company will host Investor and Analyst Day on April 22, 2026 from 10:00 AM to 12:00 PM EDT in New York.Executives will take part in Needham Virtual Psychedelics Forum panel on April 27, 2026 at 11:00 AM EDT.Definium will present at RBC Capital Markets Global Healthcare Conference on May 19, 2026 at 8:00 AM EDT in New York.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL2R23gT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624383553","title":"Definium study finds diagnosed GAD prevalence in US rises to 6.6% in 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2624383553","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624383553?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:04","pubTimestamp":1774991078,"startTime":"0","endTime":"0","summary":"Definium reported results from a retrospective, longitudinal study published in Journal of Mood and Anxiety Disorders that found diagnosed generalized anxiety disorder prevalence rose in US healthcare claims from 2020 to 2023.Study pointed to a growing burden affecting more than 1 in 10 US adults over a three-year period.Analysis linked generalized anxiety disorder with substantial comorbidity, led by major depressive disorder, reinforcing demand for more integrated care.Definium framed findings as support for accelerating development of more effective, accessible treatment options, citing limited recent innovation in generalized anxiety disorder therapies.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLbRgTjG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623853215","title":"Definium Therapeutics announces publication of study on general anxiety disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2623853215","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623853215?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:10","pubTimestamp":1774955442,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) announced results from a retrospective, longitudinal study published in the Journal of Mood and Anxiety Disorders exam...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-announces-publication-of-study-on-general-anxiety-disorder-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-announces-publication-of-study-on-general-anxiety-disorder-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623326227","title":"Definium Therapeutics issues inducement stock options for 55,580 shares to new hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2623326227","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623326227?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:04","pubTimestamp":1774901041,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issued inducement stock options covering 55,580 common shares to three newly hired non-executive employees.Grants carry effective dates of March 16, 2026, and March 30, 2026.Exercise prices match Definium closing share price on each grant date.Vesting runs four years, with 25% vesting on first anniversary of grant date.Remaining 75% vests in substantially equal monthly installments over following three years, subject to continued employment.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL29NPLD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623917338","title":"A Look At Definium Therapeutics (DFTX) Valuation As Investor Day Highlights Late Stage DT120 ODT Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2623917338","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623917338?lang=en_us&edition=fundamental","pubTime":"2026-03-29 03:09","pubTimestamp":1774724949,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) is back in focus after recent communications around its April Investor & Analyst Day, where management plans to spotlight late stage DT120 ODT data timelines in major depressive disorder and generalized anxiety disorder.\nSee our latest analysis for Definium Therapeutics.\nDefinium Therapeutics’ recent Investor & Analyst Day spotlight and earlier name change have arrived after a strong run, with a 90 day share price return of 36.91% and a very large 3 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/a-look-at-definium-therapeutics-dftx-valuation-as-investor-d","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/a-look-at-definium-therapeutics-dftx-valuation-as-investor-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DFTX","BK4007","SSI","ODT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.definiumtx.com;ir.definiumtx.com","stockEarnings":[{"period":"1week","weight":0.0534},{"period":"1month","weight":0.2857},{"period":"3month","weight":0.507},{"period":"6month","weight":0.6615},{"period":"1year","weight":2.9307},{"period":"ytd","weight":0.6938}],"compareEarnings":[{"period":"1week","weight":0.0452},{"period":"1month","weight":0.0736},{"period":"3month","weight":0.0267},{"period":"6month","weight":0.0689},{"period":"1year","weight":0.349},{"period":"ytd","weight":0.0414}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.130491},{"month":2,"riseRate":0.8,"avgChangeRate":0.136845},{"month":3,"riseRate":0.4,"avgChangeRate":0.072082},{"month":4,"riseRate":0.8,"avgChangeRate":0.046168},{"month":5,"riseRate":0.4,"avgChangeRate":-0.002468},{"month":6,"riseRate":0.4,"avgChangeRate":-0.111207},{"month":7,"riseRate":0.8,"avgChangeRate":0.20763},{"month":8,"riseRate":0.2,"avgChangeRate":-0.091548},{"month":9,"riseRate":0.2,"avgChangeRate":-0.174855},{"month":10,"riseRate":0.6,"avgChangeRate":0.009639},{"month":11,"riseRate":0.4,"avgChangeRate":0.026551},{"month":12,"riseRate":0.4,"avgChangeRate":-0.08416}],"exchange":"NASDAQ","name":"Definium Therapeutics","nameEN":"Definium Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Definium Therapeutics(DFTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Definium Therapeutics,DFTX,Definium Therapeutics股票,Definium Therapeutics股票老虎,Definium Therapeutics股票老虎国际,Definium Therapeutics行情,Definium Therapeutics股票行情,Definium Therapeutics股价,Definium Therapeutics股市,Definium Therapeutics股票价格,Definium Therapeutics股票交易,Definium Therapeutics股票购买,Definium Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Definium Therapeutics(DFTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}